本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Janux Therapeutics, Inc.

29.53
+0.25000.85%
成交量:17.11万
成交额:502.81万
市值:17.76亿
市盈率:-17.58
高:29.94
开:28.92
低:28.76
收:29.28
52周最高:71.71
52周最低:21.73
股本:6,014.78万
流通股本:4,496.69万
量比:0.80
换手率:0.38%
股息:- -
股息率:- -
每股收益(TTM):-1.6802
每股收益(LYR):-1.2836
净资产收益率:-12.48%
总资产收益率:-10.49%
市净率:1.82
市盈率(LYR):-23.01

数据加载中...

2024/12/05

重要事件披露

Form 8-K - Current report
2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/05

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/25

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities